Anah Gilmore
Overview
Explore the profile of Anah Gilmore including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
11
Citations
153
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Kallweit L, Hamlett E, Saternos H, Gilmore A, Granholm A, Horowitz S
Elife
. 2025 Feb;
14.
PMID: 39992714
As the world population ages, new molecular targets in aging and Alzheimer's disease (AD) are needed to combat the expected influx of new AD cases. Until now, the role of...
2.
Granholm A, Englund E, Gilmore A, Head E, Yong W, Perez S, et al.
Acta Neuropathol
. 2024 May;
147(1):92.
PMID: 38801558
The SARS-CoV-2 virus that led to COVID-19 is associated with significant and long-lasting neurologic symptoms in many patients, with an increased mortality risk for people with Alzheimer's disease (AD) and/or...
3.
Aldecoa I, Barroeta I, Carroll S, Fortea J, Gilmore A, Ginsberg S, et al.
Alzheimers Dement
. 2024 Jan;
20(3):2262-2272.
PMID: 38270275
Individuals with Down syndrome (DS) have a partial or complete trisomy of chromosome 21, resulting in an increased risk for early-onset Alzheimer's disease (AD)-type dementia by early midlife. Despite ongoing...
4.
Kallweit L, Hamlett E, Hamlett E, Saternos H, Gilmore A, Granholm A, et al.
bioRxiv
. 2023 Oct;
PMID: 37873355
Introduction: As the world population ages, new molecular targets in aging and Alzheimer's Disease (AD) are needed to combat the expected influx of new AD cases. Until now, the role...
5.
Colvett I, Gilmore A, Guzman S, Ledreux A, Quintero J, Ginjupally D, et al.
J Clin Med
. 2023 Oct;
12(19).
PMID: 37834764
Parkinson's disease (PD) is a severe neurological disease for which there is no effective treatment or cure, and therefore it remains an unmet need in medicine. We present data from...
6.
Ledreux A, Thomas S, Hamlett E, Trautman C, Gilmore A, Rickman Hager E, et al.
J Clin Med
. 2021 Sep;
10(17).
PMID: 34501378
Individuals with Down syndrome (DS) exhibit Alzheimer's disease (AD) pathology at a young age, including amyloid plaques and neurofibrillary tangles (NFTs). Tau pathology can spread via extracellular vesicles, such as...
7.
Ledreux A, Pryhoda M, Gorgens K, Shelburne K, Gilmore A, Linseman D, et al.
Front Neurosci
. 2020 Aug;
14:761.
PMID: 32848549
Concussion or mild traumatic brain injury (mTBI) in athletes can cause persistent symptoms, known as post-concussion syndrome (PCS), and repeated injuries may increase the long-term risk for an athlete to...
8.
RvE1 treatment prevents memory loss and neuroinflammation in the Ts65Dn mouse model of Down syndrome
Hamlett E, Hjorth E, Ledreux A, Gilmore A, Schultzberg M, Granholm A
Glia
. 2020 Jan;
68(7):1347-1360.
PMID: 31944407
Inflammation can be resolved by pro-homeostatic lipids called specialized pro-resolving mediators (SPMs) upon activation of their receptors. Dysfunctional inflammatory resolution is now considered as a driver of chronic neuroinflammation and...
9.
Bharani K, Ledreux A, Gilmore A, Carroll S, Granholm A
Neurobiol Aging
. 2019 Dec;
87:49-59.
PMID: 31882186
Disruption of brain-derived neurotrophic factor (BDNF) biosynthesis and/or signaling has been implicated in the pathogenesis of Alzheimer's disease (AD). We used postmortem brain and fluid samples from 20 patients with...
10.
Hamlett E, Ledreux A, Gilmore A, Vazey E, Aston-Jones G, Boger H, et al.
Neurobiol Dis
. 2019 Nov;
134:104616.
PMID: 31678403
The pontine nucleus locus coeruleus (LC) is the primary source of noradrenergic (NE) projections to the brain and is important for working memory, attention, and cognitive flexibility. Individuals with Down...